VC-backed Kymera Therapeutics goes public
Cambridge, Massachusetts-based Kymera Therapeutics Inc., a biopharmaceutical company, has raised $173.7 million for its IPO after pricing its over 8.6 million shares at $20 per share.
Cambridge, Massachusetts-based Kymera Therapeutics Inc., a biopharmaceutical company, has raised $173.7 million for its IPO after pricing its over 8.6 million shares at $20 per share.
Copyright PEI Media
Not for publication, email or dissemination